172
Views
11
CrossRef citations to date
0
Altmetric
Research Article

Estrogen inhibits apoptosis and promotes CC motif chemokine ligand 13 expression on synovial fibroblasts in rheumatoid arthritis

, , , , , , & show all
Pages 852-857 | Received 19 Dec 2011, Accepted 02 Feb 2012, Published online: 07 Mar 2012
 

Abstract

Objective: Female patients have a higher prevalence of rheumatoid arthritis (RA) than male patients, suggesting that female sex hormones contribute to the disease pathogenesis. We herein report the findings of our study, which was conducted to clarify the role of estrogen in the pathogenesis of RA.

Methods: Cultured human synovial fibroblasts from a patient with RA were treated with 17β-estradiol (E2). The effects of E2 against cellular activation and apoptosis were evaluated. To identify the disease-related genes altered by E2 treatment, the changes in the gene expression of the cells stimulated with and without E2 were evaluated using a microarray analysis.

Results: We found that E2-mediated cellular activation signaling through extracellular signal-regulated kinase (ERK)-1/2. E2 possessed a suppressive effect for apoptosis and a promotive effect for tumor necrosis factor (TNF)-α-induced matrix metalloproteinase (MMP)-3 production on the synovial fibroblasts. A microarray analysis revealed that E2 profoundly upregulated CC motif chemokine ligand 13 (CCL13) gene expression.

Conclusions: E2 could mediate cellular activation signaling through ERK-1/2 on the synovial fibroblasts. The present data suggest that E2 has adverse effects on the pathogenesis of RA as a result of unregulated cell death, increased TNF-α-induced MMP-3 production, and CCL13 overproduction, subsequently resulting in the disease progression of RA.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.